Company / Operating Cash Flow
Neogen Operating Cash Flow History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$58.2M
FY2024
5-year range
$35.3M / $68.0M
FY2020-FY2024
Trend
+65.2%
vs FY2023
Sector context
#115 of 158
Health Care
What the data says
At $58M, Neogen's operating cash flow ranks #115 of 158 in the Health Care sector. Operating Cash Flow returned to growth in FY2024 after 4 years of decline, reaching $58M.
Based on SEC 10-K filings.
$58M in FY2024 with a 5-year CAGR of -7.5%.
Improved from $41M to $58M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -5.0%
- 5-Year CAGR
- -7.5%
- 10-Year CAGR
- -
Sector benchmark
#115 of 158 in Health CareTop 73% of 158This company $58.2M Sector average $1.0B
▼
-94.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -7.5%, indicating a declining trend.
- In FY2024, operating cash flow increased 65.2% year-over-year.
- Ranks #115 out of 158 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $58.2M | +65.2% |
| FY2023 | $35.3M | -14.0% |
| FY2022 | $41.0M | -39.7% |
| FY2021 | $68.0M | -16.1% |
| FY2020 | $81.1M | -5.6% |
| FY2019 | $85.9M | +34.5% |
| FY2018 | $63.8M | -7.7% |
| FY2017 | $69.1M | +14.7% |
| FY2016 | $60.3M | +70.6% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026